Kerry Stokes’ Media Interest in Orthocell
Seven West Media has shown a notable focus on Orthocell, a small medtech company listed on the ASX. Orthocell is based in Perth and specializes in cell regeneration therapies.
Company Background
- Founded in 2007 as a spin-out from the University of Western Australia
- Market capitalization fluctuates around $300 million
- Stock price increased by approximately 80% over the past year
Market Context
Orthocell is just one of many smaller medtech companies listed on the ASX, making its rise and media attention particularly interesting.
“Most people wouldn’t have heard of Orthocell. It’s a Perth-based, ASX-listed medtech that makes cell regeneration therapies.”
While its growth is impressive, Orthocell remains a minor player in the larger medtech sector.
Subscription Offer
Readers can gift 5 articles per month to others when subscribing, enabling wider access to such specialized content.
Follow Developments
Stay updated on topics, people, and companies that matter to you in this evolving industry.
Author's summary: Seven West Media's growing attention to Orthocell highlights the rising significance of smaller medtech firms and their impact on the ASX market.
More News
- Nobel Prize banquet chefs and pastry chef 2025
- Where the Chefs Eat: Skye McAlpine’s Venice
- Spillcontrol – Spill Control
- Spill and pollution response
- Restaurants, hôtels, bars, caves et commerces de … - Paris
- CHEFS (@chefs_podcast) - Instagram photos and videos
- The first week of testimony in Brian Walshe’s murder trial is over. Here are takeaways from Day 5
- Is London The Top City In The World For This Cuisine? These Chefs Say Yes
- Golden State Warriors vs Cleveland Cavaliers regular season game: Full injury report, who's out, and more
- Over 4,000 gallons of oil and toxic wastewater spill in San Ardo